Table 3.
Multivariate Analysis of Risk of Second Neoplasm in Patients Treated With Growth Hormone by Initial Diagnosis40
Diagnosis | RR | 95% CI | P |
---|---|---|---|
Acute leukemia | 4.98 | 1.95 to 12.74 | < .001 |
CNS tumors | 2.34 | 0.96 to 5.70 | .06 |
CNS tumors (meningiomas excluded) | 1.46 | 0.31 to 6.79 | .69 |
Rhabdomyosarcoma | 1.82 | 0.41 to 8.01 | .43 |
Abbreviation: RR, relative risk.